Trial ID or NCT#

NCT00767624

Status

not recruiting iconNOT RECRUITING

Purpose

The aim of the proposed three-site study is to increase the rate of full remission from major depressive disorder (MDD) at the end of 16 weeks of treatment for people who experience both major depressive disorder and insomnia.

Official Title

Improving Depression Outcome by Adding Insomnia Therapy to Antidepressants

Eligibility Criteria

Ages Eligible for Study: 18 Years to 75 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Rachel Manber, PhD
Rachel Manber, PhD
Sleep specialist, Pediatric sleep specialist, Psychologist
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)

Contact us to find out if this trial is right for you.

CONTACT

SPECTRUM